As Philips stares down an international recall of more than 2 million of its CPAP ... ResMed posted year-over-year quarterly revenue growth of 14%, up to $876.1 million, with the demand for ...

ResMed’s warning on CPAP magnet interference earns FDA Class I recall tag Bi-level devices like the AirCurve 11 provide two forms of positive airway pressure therapy—with different pressure ...

SAN DIEGO, Sept. 30, 2024 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD), the world’s leading health technology company focused on sleep, breathing, and care delivered in the home, today ...

SAN DIEGO, March 06, 2024 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD ... especially for individuals requiring high-pressure CPAP treatment. The AirFit F40 addresses this problem by providing the ...

13. NEW YORK — The morning after presenting an upbeat outlook to analysts in a gilded hall in the New York Stock Exchange building, Mick Farrell, the CEO of ResMed, looked refreshed, despite a ...

ResMed Inc. RMD recently launched its first continuous positive airway pressure (CPAP) nasal mask with a memory ... Canada and most parts of Europe. Launches in the Asia-Pacific region have ...

Additionally, 54 percent said they were likely to continue offering remote CPAP setups to their new patients in the future. “ResMed MaskSelector is the digital health technology solution to HMEs ...

The recall involves some models of ResMed’s continuous positive airway pressure (CPAP) masks, AirFit and AirTouch, due to possible magnetic interference with certain medical devices and implants ...

“As a global leader in sleep health and CPAP therapy, millions of people trust ResMed’s devices to help them sleep better and live healthier lives,” said Justin Leong, ResMed chief product ...